Women Health Therapeutics Market is Anticipated to Increase at a Stable CAGR over the Forecast Period (2023 to 2029)
Women Health Therapeutics Market is anticipated to grow at a considerable CAGR of 5.3% during the forecast period. The key factors contributing to the growth of the market include a rising prevalence of chronic diseases such as cancer and others coupled with lifestyle-associated disorders in women. Moreover, an increase in investment by key market players to fulfill the disease treatment demand in areas such as infection, pregnancy-related complications, and cancers, is further propelling the market growth. According to the World Health Organization (WHO), one in every four couples has been affected by infertility in emerging economies, such as China. Under the age of 60, female infertility is ranked 5th highest serious disability across the globe. Hence, government and private companies have increased their investment to improve women's healthcare for infertility, and cancers prevailing such as cervical, ovarian, breast, and uterine cancer. According to WHO, in 2020, there were 2.3 million women diagnosed with breast cancer and 685 000 deaths globally. As of the end of 2020, there were 7.8 million women alive who were diagnosed with breast cancer.
To Request a Sample of our Report on Women
Health Therapeutics Market: https://www.omrglobal.com/request-sample/women-health-therapeutics-market-size
Women Health Therapeutics Market Segmentation
By
Type
·
Infection
·
Pregnancy
·
Oncology
·
Cervical Cancer
·
Uterine Cancer
·
Ovarian Cancer
·
Vaginal & Vular
By End-User
·
Hospital and Clinics
·
Ambulatory Centers
A full Report of Women Health Therapeutics Market is
Available @ https://www.omrglobal.com/industry-reports/women-health-therapeutics-market-size
North America
· United
States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest
of Europe
Asia-Pacific
· India
· China
· Japan
· South
Korea
· Rest
of APAC
Rest of the World
•
Latin America
•
Middle East and Africa
Company Profiles
·
Airgas, Ltd.
·
Allergan PLC
·
Amgen Inc.
·
Astellas Pharma Inc.
·
Bayer AG
·
Eli Lilly and Co
·
ICON PLC
·
Merck KGaA
·
Mithra Pharmaceuticals S.A.
·
Novo Nordisk A/S
·
Pfizer Inc.
·
Oasmia Pharmaceutical AB
·
ObsEva SA
·
Radius Health, Inc.
·
Sanofi SA
·
Takeda Pharmaceutical Co. Ltd.
·
Teva Pharmaceuticals Industries Ltd.
·
Tsumura & Co. Arkema S.A.
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More Customized Data,
Request for Report Customization @ https://www.omrglobal.com/report-customization/women-health-therapeutics-market-size
About Orion Market Research
Orion Market
Research (OMR) is a market research and consulting company known for its crisp
and concise reports. The company is equipped with an experienced team of
analysts and consultants. OMR offers quality syndicated research reports,
customized research reports, consulting and other research-based services. The
company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services
through another subsidiary Encanto Technologies.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment